Chie Morioka

520 total citations
18 papers, 340 citations indexed

About

Chie Morioka is a scholar working on Hepatology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Chie Morioka has authored 18 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hepatology, 8 papers in Surgery and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Chie Morioka's work include Liver Disease and Transplantation (8 papers), Complement system in diseases (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). Chie Morioka is often cited by papers focused on Liver Disease and Transplantation (8 papers), Complement system in diseases (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). Chie Morioka collaborates with scholars based in Japan and United States. Chie Morioka's co-authors include Hiroshi Fukui, Masahito Uemura, Hitoshi Yoshiji, Yoshihiro Fujimura, Hiromichi Ishizashi, Tatsuhiro Tsujimoto, Seiji Kato, Tomomi Matsuyama, Masanori Matsumoto and Masatoshi Ishikawa and has published in prestigious journals such as Blood, World Journal of Gastroenterology and Thrombosis and Haemostasis.

In The Last Decade

Chie Morioka

18 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chie Morioka Japan 9 183 144 115 56 52 18 340
Haruyo Iwadate Japan 11 87 0.5× 92 0.6× 56 0.5× 34 0.6× 40 0.8× 25 316
Michele Pohlen Germany 11 84 0.5× 67 0.5× 53 0.5× 70 1.3× 87 1.7× 18 313
Holly Cline-Fedewa United States 10 128 0.7× 104 0.7× 47 0.4× 44 0.8× 42 0.8× 16 334
G J Alexander United Kingdom 9 96 0.5× 64 0.4× 30 0.3× 58 1.0× 129 2.5× 12 387
Eija Tukiainen Finland 10 42 0.2× 62 0.4× 108 0.9× 27 0.5× 164 3.2× 19 360
Hyun Yang South Korea 14 238 1.3× 152 1.1× 61 0.5× 10 0.2× 67 1.3× 40 398
Jhon Prieto United States 10 140 0.8× 159 1.1× 31 0.3× 181 3.2× 61 1.2× 22 510
Yuki Tsuji Japan 14 154 0.8× 198 1.4× 34 0.3× 22 0.4× 125 2.4× 43 450
Michiko Taniguchi United States 8 118 0.6× 132 0.9× 116 1.0× 50 0.9× 176 3.4× 16 425
Xiangbo Xu China 11 232 1.3× 195 1.4× 67 0.6× 7 0.1× 117 2.3× 44 414

Countries citing papers authored by Chie Morioka

Since Specialization
Citations

This map shows the geographic impact of Chie Morioka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chie Morioka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chie Morioka more than expected).

Fields of papers citing papers by Chie Morioka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chie Morioka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chie Morioka. The network helps show where Chie Morioka may publish in the future.

Co-authorship network of co-authors of Chie Morioka

This figure shows the co-authorship network connecting the top 25 collaborators of Chie Morioka. A scholar is included among the top collaborators of Chie Morioka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chie Morioka. Chie Morioka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Takaya, Hiroaki, Kosuke Kaji, Hideto Kawaratani, et al.. (2023). Aspartate aminotransferase to platelet ratio index has utility as a biomarker of COVID‐19 severity in patients with nonalcoholic fatty liver disease. Hepatology Research. 53(11). 1047–1058. 2 indexed citations
2.
Takaya, Hiroaki, Hideto Kawaratani, Keisuke Nakanishi, et al.. (2015). Development of Nodular Regenerative Hyperplasia (NRH) with Portal Hypertension Following the Administration of Oxaliplatin for the Recurrence of Colon Cancer. Internal Medicine. 54(4). 383–387. 6 indexed citations
3.
Fukushima, Shintaro, Chie Morioka, Jun Uno, et al.. (2015). Effects of bisphosphonates on human esophageal squamous cell carcinoma cell survival. Diseases of the Esophagus. 29(6). 656–662. 8 indexed citations
4.
Kawaratani, Hideto, Takuya Kubo, Daisuke Kaya, et al.. (2014). Tuberculous peritonitis during pegylated interferon plus ribavirin combination therapy in a patient with chronic hepatitis C.. PubMed. 111(12). 2337–45. 1 indexed citations
5.
Yoshiji, Hitoshi, Ryuichi Noguchi, Tadashi Namisaki, et al.. (2013). Branched-chain amino acids suppress the cumulative recurrence of hepatocellular carcinoma under conditions of insulin-resistance. Oncology Reports. 30(2). 545–552. 16 indexed citations
6.
Takaya, Hiroaki, Masahito Uemura, Yoshihiro Fujimura, et al.. (2012). ADAMTS13 activity may predict the cumulative survival of patients with liver cirrhosis in comparison with the Child‐Turcotte‐Pugh score and the Model for End‐Stage Liver Disease score. Hepatology Research. 42(5). 459–472. 35 indexed citations
7.
Shirai, Yusaku, Hitoshi Yoshiji, Saiho Ko, et al.. (2011). Salvage living donor liver transplantation after percutaneous transluminal angioplasty for recurrent Budd-Chiari syndrome: a case report. Journal of Medical Case Reports. 5(1). 124–124. 2 indexed citations
8.
Yoshiji, Hitoshi, Ryuichi Noguchi, Yasuhide Ikenaka, et al.. (2010). Soluble VEGF receptor-2 may be a predictive marker of anti-angiogenic therapy with clinically available safe agents. Oncology Letters. 2(1). 69–73. 7 indexed citations
9.
Kitade, Mitsuteru, Hitoshi Yoshiji, Ryuichi Noguchi, et al.. (2009). Crosstalk between angiogenesis, cytokeratin-18, and insulinresistance in the progression of non-alcoholic steatohepatitis. World Journal of Gastroenterology. 15(41). 5193–5193. 37 indexed citations
10.
Matsumoto, Masanori, Hiromichi Ishizashi, Seiji Kato, et al.. (2008). Comprehensive analysis of ADAMTS13 in patients with liver cirrhosis. Thrombosis and Haemostasis. 99(6). 1019–1029. 104 indexed citations
11.
Ishikawa, Masatoshi, Masahito Uemura, Tomomi Matsuyama, et al.. (2008). Potential Role of Enhanced Cytokinemia and Plasma Inhibitor on the Decreased Activity of Plasma ADAMTS13 in Patients With Alcoholic Hepatitis: Relationship to Endotoxemia. Alcoholism Clinical and Experimental Research. 34(s1). S25–33. 28 indexed citations
12.
Morioka, Chie, Masahito Uemura, Tomomi Matsuyama, et al.. (2008). Plasma ADAMTS13 activity parallels the APACHE II score, reflecting an early prognostic indicator for patients with severe acute pancreatitis. Scandinavian Journal of Gastroenterology. 43(11). 1387–1396. 25 indexed citations
13.
Uemura, Masahito, Yoshihiro Fujimura, Tomomi Matsuyama, et al.. (2008). Potential Role of ADAMTS13 in the Progression of Alcoholic Hepatitis. Current Drug Abuse Reviews. 1(2). 188–196. 7 indexed citations
14.
Ishikawa, Masatoshi, Masahito Uemura, Tomomi Matsuyama, et al.. (2008). Potential Role of Enhanced Cytokinemia and Endotoxemia on the Decreased Activity of Plasma ADAMTS13 in Patients with Alcoholic Hepatitis.. Blood. 112(11). 2292–2292. 1 indexed citations
15.
Sakaguchi, Hiroshi, Toshihiro Tanaka, Nagaaki Marugami, et al.. (2007). Cystic echinococcosis in immigrant from Peru: First case treated with percutaneous treatment in Japan. Parasitology International. 56(3). 207–210. 3 indexed citations
16.
Matsuyama, Tomomi, Masahito Uemura, Masatoshi Ishikawa, et al.. (2007). Increased von Willebrand Factor Over Decreased ADAMTS13 Activity May Contribute to the Development of Liver Disturbance and Multiorgan Failure in Patients With Alcoholic Hepatitis. Alcoholism Clinical and Experimental Research. 31(s1). S27–35. 33 indexed citations
17.
Imazu, Hiroo, Masahiko Matsumura, Chie Morioka, et al.. (2005). Sclerotherapy for gastric fundal variceal bleeding: Is complete obliteration possible without cyanoacrylate?. Journal of Gastroenterology and Hepatology. 20(11). 1701–1706. 11 indexed citations
18.
Fukutani, Miki, Kinuko Tajima, Yuka Tanaka, et al.. (1992). Feasibility Study on Quality-of-life Questionnaires for Patients with Advanced Lung Cancer. Japanese Journal of Clinical Oncology. 22(3). 185–93. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haruyo Iwadate Breakdown of academic impact, for papers by Michele Pohlen Breakdown of academic impact, for papers by Holly Cline-Fedewa Breakdown of academic impact, for papers by G J Alexander Breakdown of academic impact, for papers by Eija Tukiainen Breakdown of academic impact, for papers by Hyun Yang Breakdown of academic impact, for papers by Jhon Prieto Breakdown of academic impact, for papers by Yuki Tsuji Breakdown of academic impact, for papers by Michiko Taniguchi Breakdown of academic impact, for papers by Xiangbo Xu
Rankless by CCL
2026